
    
      Patient enrolment and data aquisition is to be carried out on a prospective basis. It is
      planned to enrol 40 patients with stable COPD and 40 patients with AE-COPD. All patients will
      undergo blood sampling inlcuding SAA and Lipoxin A4.
    
  